The Abuja +12 Declaration: Implications for HIV Response in Africa

Rosemary W Mburu, Morenike Oluwatoyin Folayan, Olayide Akanni

Abstract

Heads of State and Governments of the Organization of African Unity now the African Union (AU) met in April 2001 at a Special Summit held in Abuja to address the challenges of HIV/AIDS, Tuberculosis, Malaria and other related infectious diseases in Africa. In May 2006, at the Special Summit under the theme: “Universal Access to HIV/AIDS, Tuberculosis and Malaria Services by 2010”, the African Union Heads of States and Governments adopted the “Abuja Call for Accelerated Action towards Universal Access to HIV/AIDS, Tuberculosis and Malaria Services in Africa” and related commitments thus reaffirming earlier commitments.  In July 2013, African leaders once again gathered in Abuja for the Abuja +12 summit, which focused on the theme ‘Ownership, Accountability and Sustainability of HIV/AIDS, Tuberculosis and Malaria in Africa: Past, Present and the Future’. At the meeting, African leaders noted the tremendous progress that has been made in addressing HIV and AIDS, and made further commitments to effectively tackle the HIV epidemic on the continent. This article presents a critical look at each of these commitments and makes recommendations that would assist African countries in developing policies to end the HIV/AIDS epidemic in the region. (Afr J Reprod Health 2014; 18[3]: 34-46)

 

Keywords: Abuja declaration; HIV infections; combination prevention; research for preventive measures; domestic resource mobilization

Résumé 

Les Chefs d'Etat et de gouvernements de l'Organisation de l'unité africaine devenue l'Union africaine (UA) se sont réunis en avril 2001, à un Sommet extraordinaire tenu à Abuja pour relever les défis du VIH / SIDA, de la tuberculose, du paludisme et d'autres maladies infectieuses connexes en Afrique. En mai 2006, lors du Sommet extraordinaire sur le thème: «Accès universel aux services du VIH / SIDA, de la tuberculose et du paludisme  d'ici  2010", les chefs d'Etats et de gouvernements de l'Union africaine ont adopté l’ «Appel d'Abuja pour une action accélérée vers l'accès universel aux services du VIH / SIDA,  de la tuberculose et du  paludisme  en Afrique » et les engagements connexes réaffirmant ainsi ses engagements antérieurs. En juillet 2013, les dirigeants africains se sont réunis une fois de plus à Abuja pour le sommet d'Abuja  +12, qui portait sur le thème «La propriété, la responsabilité et la durabilité du VIH / SIDA, de la tuberculose et du paludisme en Afrique: le passé, le présent et l'avenir». Lors de la réunion, les dirigeants africains ont noté les progrès considérables qui ont été accomplis dans la lutte contre le VIH et le sida, et ont pris des engagements supplémentaires sur un certain nombre de questions dans les moyens de lutter efficacement contre l'épidémie du VIH sur le continent. Cet article présente un regard critique sur chacun de ces engagements et fait des recommandations qui aideraient les pays africains à élaborer des politiques pour mettre fin à l'épidémie du VIH / SIDA dans la région. (Afr J Reprod Health 2014; 18[3]: 34-46)

Full Text:

PDF

References

Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010; 329(5996):11681174.

Grant, RM, Lama JR, Anderson PL, et al. Pre-exposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. New England Journal of Medicine 2010; 363(27): 2587-2599.

Baeten, JM, Donnell D, Ndase P, et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. New England Journal of Medicine 2012;367(5):399-410.

Thigpen, MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. New England Journal of Medicine 2012; 367(5):423-434.

Choopanya K, Martin M, Suntharasamai, et al, for the Bangkok Tenofovir Study Group. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo controlled phase 3 trial. Lancet 2013; 381(9883):2083-2090.

Cohen, MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New England Journal of Medicine 2011; 365(6): 493505.

Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomised, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265Trial. PLoS Med. 2005; 2(11):e298. Epub 2005 Oct 25.

Gray RH, Kigozi G, Serwadda D, et al Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 200; 369(9562):657-666.

Bailey RC, Moses S, Parker CB, Agot K, Maclean

I, Krieger JN, Williams CF, Campbell RT, NdinyaAchola JO. Male circumcision for HIV prevention in young men in Kisum, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562):643-656.

World Health Organisation. Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa: January - December, 2011. http://www.malecircumcision.org/ country_updates/documents/FINAL%20VMMC%20P rogress%20Report%20Jan-Dec%202011%20WHO. pdf. Accessed 12th April, 2014.

What is IPrEx OLE. http://www.iprexole .com/ 1 pages/ aboutus/aboutus-whatisiprexole.php. Accessed 5th November, 2011.

Press Release. SFDPH to Launch PrEP Demonstration Project for HIV Prevention. http://www.iprexnews. com/content/whatisnew.html. Accessed 5th November ,2012

Partners Demonstration Project. http://depts. washington.edu/uwicrc/research/studies/demo. html. Accessed 16th February, 2014.

Facts Consortium. FACTS 001b Study. http://www.factsconsortium.co.za/?page_id=83. Accessed 12th April 2014.

World Health Organisation. Next steps 1% Tenofovir Gel. Department of Reproductive Health and Research. Johannesburg, South Africa. 25–26 August 2010. http://www.who.int/reproductivehealth/topics/rtis/WH O_UNAIDS_Next_steps_tenofovir_gel_Ex_sum.pdf. Accessed 12th April, 2014.

Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G; Tugela Ferry Care and Research (TF CARES) Collaboration. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis. 2007;196 Suppl 3:S482-S490.

Fauci AS; NIAID Tuberculosis Working Group. Multidrug-resistance and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. J Infect Dis. 2008; 197(11): 1493-1498.

Schwartz L, Brown GV, Genton B, Moorthy VS. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J. 2012;11:11. doi: 10.1186/1475-2875-11-11.

Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, et al. Pre-exposure Prophylaxis for HIV in Women: Daily Oral Tenofovir, Oral Tenofovir/Emtricitabine, or Vaginal Tenofovir Gel in the VOICE Study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, March 3–6, 26LB. 2013.

Van Damme L, Corneli A, Ahmed K, et al. Pre-exposure Prophylaxis for HIV Infection among African Women. New Engl J Med 2012; 367: 411-422

Joint United Nations Programme on HIV/AIDS (UNAIDS). Combination HIV prevention: tailoring and coordinating biomedical, behavioural and structural strategies to reduce new HIV infections: a UNAIDS discussion paper. http://www.unaids. org/ en /media/unaids/contentassets/documents/unaidspublicat ion/2010/JC2007_Combination_Prevention_paper_en. pdf. Accessed 12th April, 2014.

Kippax S. Effective HIV prevention: the indispensable role of social science. J Int AIDS Soc. 2012; 15(2):17357. doi: 10.7448/IAS.15.2.17357.

Declaration of the Special Summit of the African Union on HIV/AIDS, Tuberculosis and Malaria. http:// abujaplus12.org/abuja12-summit-declaration/ accessed 12 April, 2014.

UNFPA. The human right based approach. http:// www.unfpa.org/rights/approaches.htm. Accessed 12th April 2014.

Chen J, Choe MK, Chen S, Zhang S. Community environment and HIV/AIDS related stigma in China. AIDS Educ Prev. 2005;17:1–11.

Liu H, Hu Z, Li X, et al. Understanding the interrelationships among HIV-related stigma, concern about HIV infection, and intent to disclose HIV serostatus: a pretest-posttest study in a rural area of Eastern China. AIDS Patient Care &

STDs. 2006;20:133–142.

Simbayi LC, Kalichman SC, Strebel A, et al. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect. 2007;83:29–34.

Peretti-Watel P, Spire B, Obadia Y, et al. Discrimination against HIV-infected people and the spread of HIV:

some evidence from France. PLoS One. 2007;2:e411.

Varga CA, Sherman GG, Jones SA. HIV-disclosure in the context of vertical transmission: HIV-positive mothers in Johannesburg, South Africa. AIDS Care. 2006; 18:952–960.

Eide Mhyre M, Lindbaek M, et al. Social consequences of HIV-positive women’s participation in prevention of mother-to-child transmission programmes. Patient

Educ Couns. 2006;60:146–151

Obermeyer CM, Obsorn M. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. APJH. 2007;97:1762–1774.

Pool R, Nyanzi S, Whitworth JAG. Attitudes toward voluntary counseling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care. 2001;13:605–615.

Kinsler JJ, Wong MD, Sayles JN, et al. The effect of perceived stigma from a healthcare provider on access to care among a low-income HIV-positive

population. AIDS Patient Care & STDs. 2007;21:584– 592.

Rajabiun S, Mallinson RK, McCoy K, et al. Getting me back on track: the role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care &

STDs. 2007;21 (Suppl 1):S20–S29.

Reif S, Golin CE, Smith SR. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care. 2005;17:558–565.

Rao D, Kekwaletswe TC, Hosek S, et al. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19:28–33.

Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma, and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18:904–910.

Rintamaki LS, Davis TC, Skripkauskas S, et al. Social stigma concerns and HIV medication

adherence. AIDS Patient Care & STDs. 2006;20:359– 368.

Sayles JN, Wong MD, Cunningham WE. The inability to take medications openly at home: does it explain gender disparities in HAART use? J Women's Health (Larchmt) 2006;15:173–181.

Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, Szekeres G, Coates TJ. Stigma in the HIV/AIDS epidemic: a review of

the literature and recommendations for the way forward. AIDS. 2008; 22:S67-S79.

The Federal Republic of Nigeria. Same sex (marriage) prohibition Act. 2013.

GayStarNews. Two Nigerians acquitted by Islamic court over gay sex allegations. Available at http://www . gaystarnews.com/article/two-nigerians-acquittedislamic-court-over-gay-sex-allegations020414# sthash.jF1LqRCp.dpuf Accessed 5th July, 2014.

Taylor A. Meet the first man to come out as gay on Nigerian television. The Washington Post. April 15th 2014. Available at http://www. Washingtonpost . com/blogs/worldviews/wp/2014/04/15/meet-the-firstman-to-come-out-as-gay-on-nigerian-television/. Accessed on 5th July, 2014.

Global HIV Prevention Working Group. Access to HIV prevention: closing the gap; 2003. http://www. globalhivprevention.org/pdfs/Funding%20Report%20 FINAL.pdf. Accessed 31 March 2014.

UNAIDS. Combination Prevention: strategic HIV prevention programmes founded on good practice. A background paper for the UNAIDS Prevention Reference Group Meeting; 3–5 December 2009. Geneva: UNAIDS; 2009.

UNAIDS. AIDS epidemic update. Geneva: Joint United Nations Programme on HIV/AIDS; 2006.

Hankins CA, de Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS 2010; 24: S70–S80.

Jewkes R, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: A cohort study. Lancet 2010. 376(9734): 41 – 48.

Jewkes R, Dunkle K, Nduna M, Shai N. Factors associated with HIV sero-status in young rural South African women: connections between intimate partner violence and HIV. Int J Epidemiology 2006; 35: 1461-1468.

Binagwaho A, Fuller A, Kerry V, Dougherty S, Agbonyitor M, Wagner C, Nzayizera R, & Farmer P. Adolescents and the right to health: Eliminating age- related barriers to HIV/AIDS services in Rwanda. AIDS Care 2012. 24 (7): 936–942.

Global HIV Prevention Working Group. Access to HIV prevention: closing the gap; 2003. http://www. globalhivprevention.org/pdfs/Funding%20Report%20 FINAL.pdf. Accessed 28 March 2014.

UNAIDS. Global Plan Towards the Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive. UNAIDS 2011.

UNAIDS. Report on the Global AIDS Epidemic. UNAIDS 2010. http://www.unaids.org/documents/ 20101123_GlobalReport_em.pdf. Accessed 28th March 2014.

United Nations Population Fund. Reproductive health in refugee situations. An inter-agency field manual. UNFPA 1999: http://www.unfpa.org. Accessed 28th March 2014

World Health Organization. Glion consultation on strengthening the linkages between reproductive health and HIV/AIDS: Family planning and HIV/AIDS in women and children. WHO 2006: http://www.who.int. Accessed 28th March 2014.

Church K, Mayhew SH. Integration of STI and HIV prevention, care, and treatment into family planning services: a review of the literature. Stud Fam Plan 2009; 40:171–186.

Barroso C, Sippel S. Sexual and Reproductive Health and Rights: Integration as a Holistic and Rights-Based Response to HIV/AIDS. Women's Health Issues 2011: 21-6S; S250–S254.

Church K, Lewin S. Delivering integrated HIV services: time for a client-centred approach to meet the sexual and reproductive health needs of people living with HIV? AIDS. 2010; 24 (2):189–193.

Johnson K, Ilona V, Paul A. Integration of HIV and Family Planning Health Services in Sub-Saharan Africa: A Review of the Literature, Current Recommendations, and Evidence from the Service Provision Assessment Health Facility Surveys. DHS Analytical Studies No. 30. Calverton, Maryland, USA 2012: ICF International.

Hladik W, Stover J, Esiru G, Harper M, & Tappero J. The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PloS one 2009: 4(11), e7691.

Reynolds HW, Steiner MJ, Cates W Jr. Contraception's proved potential to fight HIV. Sex Transm Infect 2005: Apr;81(2):184-185.

Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006: Jun; 33(6): 350356.

Reynolds H, Toroitich-Ruto C, Nasution M, BeastonBlaakman A, Janowitz B. Effectiveness of training supervisors to improve reproductive health quality of care: a cluster- randomized trial in Kenya. Health Policy Planning 2008. Jan; 23(1): 56-66. Epub 2007 Oct 17.

Ministry of Public Health and Sanitation and Ministry of Medical Services, Republic of Kenya. (2009). National Reproductive Health and HIV and AIDS Integration Strategy. http://pdf.usaid.gov/ pdf_docs /PNADX858.pdf. 2009. Accessed 1st April 2014.

TB Alliance. TB and HIV/AIDS. Available at http://www.tballiance.org/why/tb-hiv.php. Accessed on 5th July, 2014.

Implementation of the Abuja Call or Accelerated Action Towards Universal Access to HV/AIDS, Tuberculosis and Malaria Services Progress Report 2010 -2012

UNAIDS. Access to Antiretroviral Therapy in Africa. Status Report on Progress Towards the 2015 Targets. UNAIDS 2013. http://www.unaids.org /en/media/ unaids/contentassets/documents/unaidspublication/20 13/20131219_AccessARTAfricaStatusReportProgress towards2015Targets_en.pdf. Accessed 1st April 2014

WHO. Global update on HIV Treatment 2013: Results, Impact and Opportunities. WHO 2013.

UNAIDS and WHO. HIV and Adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV. WHO 2013.

UNAIDS. Report on global AIDS epidemic 2013. Geneva: UNAIDS; 2013 (http://www.unaids.org/en/ media/unaids/contentassets/documents/epidemiology/ 2013/gr201 3/UNAIDS_Global_Report_2013_en.pdf. Accessed on 2nd April 2014.

United Nations Children’s Fund, Towards an AIDS-Free Generation – Children and AIDS: Sixth Stocktaking Report, 2013, UNICEF, New York, 2013. http://www. childrenandaids.org/files/str6_full_report_29-112013.pdf. Accessed 7th April 2014.

Nachega J, Hislop M, Nguyen H, et al. Antiretroviral Therapy Adherence, Virological and Immunological Outcomes in Adolescents Compared with Adults in Southern Africa. J. Acquir. Immune Defic. Syndr. 2009; 51(1):65-71.

Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24: 621–635.

Cohen J. Anti-HIV pill protects against AIDS. Science NOW. Nov 23, 2010. http://news. sciencemag. Org / health/2010/11/anti-hiv-pill-protects-against-aids. Accessed 9th April 2014.

World Health Organisation. The Abuja Declaration: ten years on. http://www.who.int/ healthsystems/ publications/Abuja10.pdf. Accessed 16th February, 2014.

The world health report - Health systems financing: the path to universal coverage. http://www.who. int/entity/whr/2010/whr10_en.pdf?ua=1. Accessed 16th February, 2014

Volmink J, Dare L. Addressing inequalities in research capacity in Africa. BMJ. 2005;331:705–706.

Osei-Atweneboana MY; Lustigman S, Prichard RK, Boatin BA, Basanez MG. A research agenda for helminth diseases of humans: health research and capacity building in disease-endemiccountries for helminthiases control. PLos Negl Trop Dis. 2012;6(4): e1602. doi:10.1371/journal.pntd. 0001602. Epub 2012

Apr 24.

The Bamako call to action: research for health. The Lancet 2008; 372 (9653): 1855doi:10.1016/ S0140-6736(08)6178.

Laeyendecker O, Piwowar-Manning E, Fiamma A, et al. Estimation of HIV incidence in a large, communitybased, randomized clinical trial: NIMH project accept

(HIV Prevention Trials Network 043). PLoS One. 2013 Jul 11;8(7):e68349. doi: 10.1371/journal.pone .0068349.

Henry K. Documented male-to-female transmission of HIV-1 after minimal vaginal exposure in the absence of other cofactors for infection. Minn Med. 1991; 74 (10):32-34.

Baggaley RF, White RG, Boily MC: HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010; 39:1048-1063.

Ferguson LM, Rohan LC. The importance of the vaginal delivery route for antiretroviral in HIV prevention. Ther Deliv. 2011; 2(12):1535-1550.

Spreen WR, Margolis DA, Pottage JC Jr. Long-acting injectable antiretrovirals for HIV treatment and prevention.Curr Opin HIV AIDS. 2013; 8(6):565571.

Fauci AS, Marston HD. Ending AIDS--is an HIV vaccine necessary? N Engl J Med. 2014 Feb 6;370(6):495-8. doi: 10.1056/NEJMp1313771.

WHO. Global strategy and plan of action on public health, innovation and intellectual property. WHO 2011. http://www.who.int/phi/publications/Global_Strategy_ Plan_Action.pdf. Accessed 9th April 2014

World Health Organization (WHO). Improving access to medicines in Thailand: the use of TRIPS flexibilities: report of a WHO mission, Bangkok, 31 January to 6 February 2008. Geneva, WHO 2008b. http://www. moph.go.th/hot/THAIMissionReport%20FINAL15feb 08.pdf. Accessed 9th April 2014

UNAIDS. Political declaration on HIV/AIDS. General Assembly Resolution 60/262, Article 20. Paragraph 42. Geneva, UNAIDS, 2006. http://data.unaids. org/ pub/Report/2006/20060615_HLM_Political Declaration_ARES60262_en.pdf. Accessed 9th April 2014.

Habte D. Building and strengthening research capacity in health: the challenge to Africa. J Diarrhoeal Dis Res 1992; 10: 73-78.

Council on Health Research for Development. Essential national health research and priority setting: lessons learned. Geneva: Council on Health Research for Development, 1997.

Chandiwana SK, Shiff CJ. Science-based economic development––the Eureka factor. Zimbabwe Sci News 1999; 33: 5-11.

Refbacks

  • There are currently no refbacks.